Cholesterol promotes the formation of dimers and oligomers of the receptor tyrosine kinase ROR1
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2025.111000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Alyssa Ward und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Cellular and Molecular Biology, University of Tennessee, Knoxville, USA. Hauptthemen laut MEDLINE: Receptor Tyrosine Kinase-like Orphan Receptors, Protein Multimerization, Cholesterol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Ministerio de Ciencia, Innovación y Universidades, University of Tennessee.
Abstract (Originalsprache)
Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is a member of the receptor tyrosine kinase (RTK) family that plays a crucial role during organogenesis of bone and neural systems by regulating noncanonical Wnt signaling. Misregulation of ROR1 is additionally a causative factor for carcinogenesis in solid and liquid tumors. However, we have a poor understanding of how ROR1 activity is regulated. We employed a recently developed single-molecule method termed SiMPull-POP to study the oligomeric state of ROR1. RTK function is typically triggered by ligand binding, which promotes self-assembly of RTKs to form dimers and in some cases oligomers. However, our data indicate that ROR1 does not follow this paradigm. Instead, ROR1 forms dimers and oligomers in a process that is not affected by the presence of the ROR1 ligand Wnt5a. Additional experiments indicate that the transmembrane domain of ROR1 has a strong tendency to self-assemble, suggesting that this domain modulates ROR1 dimerization. Investigation into a regulatory mechanism for ROR1 self-assembly led to evaluation of the role of the lipid cholesterol, which plays pleiotropic roles in Wnt signaling. Cholesterol was found to promote the assembly of ROR1, and our results point to the transmembrane domain as the region where cholesterol exerts this regulatory effect. Taken together, our results indicate that ROR1 self-assembles in human cells; however, unlike other RTKs, this process is not stabilized by ligand binding but is instead facilitated by membrane cholesterol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Cellular and Molecular Biology, University of Tennessee, Knoxville, USA.
- Departament de Bioquímica i Biologia Molecular, Institut Universitari en Biotecnologia i Biomedicina (BioTecMed), Facultat de Ciències Biològiques, Universitat de València, Burjassot, Spain.
- Department of Biochemistry & Cellular and Molecular Biology, University of Tennessee, Knoxville, USA. Electronic address: fbarrera@utk.edu.
Förderung
- NIGMS NIH HHS
- Ministerio de Ciencia, Innovación y Universidades
- University of Tennessee
- Generalitat Valenciana
- National Institute of General Medical Sciences
- National Institutes of Health
Zitieren
APA
Ward, A., Baeza-Ballesteros, L. J., Schuck, R., García-Murria, M. J., Lamichhane, R., Mingarro, I., & Barrera, F. N. (2026). Cholesterol promotes the formation of dimers and oligomers of the receptor tyrosine kinase ROR1. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.111000
Vancouver
Ward A, Baeza-Ballesteros LJ, Schuck R, García-Murria MJ, Lamichhane R, Mingarro I, et al. Cholesterol promotes the formation of dimers and oligomers of the receptor tyrosine kinase ROR1. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2025.111000
BibTeX
@article{Ward2026,
author = {Ward, Alyssa and Baeza-Ballesteros, Luis J and Schuck, Ryan and García-Murria, Maria J and Lamichhane, Rajan and Mingarro, Ismael and Barrera, Francisco N},
title = {Cholesterol promotes the formation of dimers and oligomers of the receptor tyrosine kinase ROR1},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2025.111000}
}
EUVIMED